Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Single-arm Study of the Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease Who Are Carriers of the ε4 Variant of the Apolipoprotein E Gene (APOE4/4 or APOE3/4)

NCT04693520 is registered in ClinicalTrials.gov with Alzheon Inc. as lead sponsor.

NCT NCT04693520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04693520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Single-arm Study of the Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease Who Are Carriers of the ε4 Variant of the Apolipoprotein E Gene (APOE4/4 or APOE3/4)
Lead sponsor
Alzheon Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2020
Completion date
July 16, 2025
Enrollment
84 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

early alzheimer's disease